Why This Recall Changed How Dermatologists View Benzoyl Peroxide
Benzoyl peroxide has long been a go-to treatment for acne. Doctors recommend it because it kills bacteria on the skin and helps clear pores. You can find it in gels, creams, and washes sold over the counter. For years, it was seen as safe and effective for most people with mild to moderate breakouts.[1]
That view started to shift in a big way during 2025. It began with tests from Valisure, an independent lab. They checked acne products and found benzene, a chemical linked to cancer, in some that contained benzoyl peroxide. Benzene is not supposed to be in these treatments. The levels were higher than what regulators consider safe.[1]
In March 2025, L’Oreal took action. The company recalled all lots of its Effaclar Duo product, sold under the La Roche-Posay brand in the US. This acne treatment uses benzoyl peroxide. The recall came directly from worries about benzene contamination.[1]
The issue did not stop there. The FDA got involved. They issued alerts about more testing on benzoyl peroxide products. Additional companies did voluntary recalls too. The FDA planned to share full test results soon after.[4]
Dermatologists paid close attention. Before this, benzoyl peroxide was praised for few serious side effects beyond dryness or redness. Now, experts had to weigh cancer risks from benzene against its benefits. Benzene forms when benzoyl peroxide breaks down, especially if stored poorly or exposed to heat.[1][4]
This led to changes in how skin doctors approach it. Many now suggest lower strengths, like 2.5% or 5%, over higher ones. They tell patients to store products in cool, dark places and check expiration dates. Some recommend alternatives for long-term use, such as retinoids or salicylic acid, to limit exposure.[4]
Patient trust became a key concern. With news spreading fast online, people questioned acne treatments they had used for years. Dermatologists stepped up to explain the risks are low for short-term use but stressed caution. They now discuss benzene testing in visits and push for better manufacturing standards.[1][4]
The recall highlighted gaps in product safety checks. Valisure had flagged the problem over a year earlier, urging the FDA to act. This pushed regulators and companies to test more rigorously. Dermatologists see it as a wake-up call to monitor ingredients closely, even in familiar drugs.[1]
Today, benzoyl peroxide remains on shelves and in offices. But its role has evolved. Doctors view it as a solid option when used smartly, with new emphasis on safety data and patient education.
Sources
https://www.dermatologytimes.com/view/top-10-articles-of-the-year-2025
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=950edb4e-fbba-41e3-9ec5-973806e555e7&version=21
https://medshadow.org/conditions-treatments/skin/5-common-drug-reactions-that-affect-the-skin/
https://www.dermatologytimes.com/view/dermatology-times-2025-year-in-review-acne
